Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 and ...

With a market cap of $50.5 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions provider specializing in pharmaceutical distribution and related services.

Cencora has made headlines with its announcement on March 10, 2025, detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth.

Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 6.2% over the past month. The stock hit a new 52-week high of $262.56 in the previous session.

In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against other stocks with at least $30 million in insider sales recently. Last week, stocks declined in part ...

We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against other ...

In a recent 8-K filing with the Securities and Exchange Commission, Cencora, Inc., a Delaware-based company in the wholesale drug industry and a prominent player in Healthcare Providers & Services ...